Mustaca-Kaiser v. Pfizer Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Mustaca-Kaiser v. Pfizer Inc

Sort by

Viewing results 1‒22 of 22

Covid-19 vaccines
FDA approves BioNTech/Pfizer jab for 5 to 11-year-olds
...A recent survey by the Kaiser Family Foundation showed almost a third of parents would “definitely” not get their kids vaccinated....
October 29, 2021
News in-depthCovid-19 vaccines
US battles to sell parents on benefits of ‘kid-sized’ jabs for children
...The BioNTech/Pfizer jab will be dispensed in “kid-sized” doses, a third of the size of those for people aged 12 years and more....
November 4, 2021
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Covid-19 vaccines
Pfizer and Moderna forecast to almost double vaccine sales in 2022
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
October 18, 2021
Covid-19 vaccines
Pfizer and Moderna say Covid vaccine protection wanes over time
...Ahead of a crucial meeting of the Food and Drug Administration vaccines advisory committee on Friday to discuss its booster proposal, Pfizer on Wednesday submitted a study by Kaiser Permanente Southern California...
September 15, 2021
Covid-19 vaccines
Africa will pay more for Russian Covid vaccine than ‘western’ jabs
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
February 25, 2021
Covid-19 vaccines
J&J vaccine pause threatens to dent public confidence, warn experts
...Liz Hamel, who directs polling at the Kaiser Family Foundation health think-tank, said: “We know that side effects are people’s biggest concern about the vaccine....
April 14, 2021
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
FT AlphavilleCoronavirus
The ESG case for the Oxford/AstraZeneca vaccine
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
December 23, 2020
Coronavirus treatment
EU fast-tracks process for Pfizer and BioNTech’s Covid-19 vaccine
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
October 6, 2020
Drug prices
Pharmacy benefit managers face bipartisan criticism
...The three leading companies count 71 per cent of Medicare patients enrolled in prescription drug plans as their customers, according to the Kaiser Family Foundation, a healthcare research institution....
April 9, 2019
Health
FT Health: The NHS and funding for health
...(NYT, New Statesman) Dementia drug blow The difficulty of finding drugs to treat Alzheimer's and Parkinson's diseases was underlined by Pfizer's withdrawal from research....
January 12, 2018
US & Canadian companies
Amazon, Berkshire and JPMorgan join forces to shake up healthcare
...Shares of large drugmakers also tumbled, as investors fretted they would struggle to maintain premium prices, with Pfizer, AbbVie and Merck losing between 1.6 per cent and 5.3 per cent....
January 30, 2018
Cyber Security
FT Health: The security challenge
...(Stat) UK life sciences laggard A report for pharma giant Pfizer says Britain is falling behind in the prescription of new medicines, despite its prowess in science and a skilled workforce....
August 4, 2017
Neglected tropical diseases
FT Health: New WHO chief faces tough challenges
...(FT, The Lancet) Depression test questioned Campaigners say doctors could be misdiagnosing depression by being too reliant on a questionnaire devised by Pfizer — a maker of antidepressant drugs....
May 26, 2017
LexMergers & Acquisitions
Letter from Lex: let’s make a deal
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
May 16, 2014
beyondbricsNeil Munshi
Ranbaxy’s high blood pressure day
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
November 30, 2011
FT Live
FTWeekend Festival: U.S. edition
Where the Financial Times weekend paper comes to life
Saturday, 4 MayThe REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
US equities
Altria gains on court snub to anti-tobacco
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
June 28, 2010
News in-depthWorld
HIV / Aids: Discordant visions
...A survey released this week by the Kaiser Family Foundation, a US think tank, shows disbursement for Aids from international donors already slipping, from $7.7bn in 2008 to $7.6bn in 2009, after a sixfold...
July 22, 2010
ReviewLife & Arts
The Three Emperors
...But the parallel interrelated lives of Kaiser Wilhelm II, George V and Nicholas II are more than that....
September 28, 2009
FT AlphavilleEquities
CDS report: Spreads widen as investors await earnings season
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
July 6, 2009
News in-depthUK economy
Raised spirits
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
September 11, 2009
Mergers & Acquisitions
Signatories: ICC letter on the Doha Round to the editor of the Financial Times
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
February 28, 2007
Work & Careers
The big defence challenge
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
April 20, 2005

Previous pagePage 1 of 1Next page